UK Launches Inquiry Into Its Clinical Trials Problems After Pharma Outcry

Ex-Health Minister To Report Back In Spring

Stung by criticism from the AstraZeneca and GSK CEOs, the UK government has launched an independent review into commercial clinical trials in the hopes of reversing a steep decline.

NHS — Delays to clinical trial initiation and poor recruitment levels are endangering the UK's status as a leading nation for commercial research. • Source: Shutterstock

The UK government hopes a new independent review can help find ways to halt a steep decline in the number of commercial clinical trials being conducted in the country.

The review, announced on 20 February, follows an outcry from the UK pharma industry association and critical comments from the...